Impairment of Skin Wound Healing in β -1,4-Galactosyltransferase-Deficient Mice with Reduced Leukocyte Recruitment

American Journal of Pathology

Volumn 164, Issue 4, 2004, Pages 1303-1314

  Mori, Ryoichi ^a   Kondo, Toshikazu ^a,b   Nishie, Toshikazu ^a   Ohshima, Tohru ^a   Asano, Masahide ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,4 GALACTOSYLTRANSFERASE; CARBOHYDRATE; CHEMOKINE; COLLAGEN; GALACTOSYLTRANSFERASE; GLYCAN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL INFILTRATION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME DEFICIENCY; EPIDERMIS CELL; EPITHELIZATION; LEUKOCYTE ACTIVATION; MACROPHAGE; MOUSE; MUTANT; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN INJURY; WOUND HEALING IMPAIRMENT;

EID: 1642285950     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63217-8     Document Type: Article

References (47)

1. Martin P: Wound healing-aiming for perfect skin regeneration. Science 1997, 276:75-81
2. Singer AJ, Clark RA: Cutaneous wound healing. N Engl J Med 1999, 341:738-746
3. Keane MP, Strieter RM: The role of CXC chemokines in the regulation of angiogenesis. Chem Immunol 1999, 72:86-101
4. Campbell JJ, Butcher EC: Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol 2000, 12:336-341
5. Rossi D, Zlotnik A: The biology of chemokines and their receptors. Annu Rev Immunol 2000, 18:217-242
6. Sallusto F, Mackay CR, Lanzavecchia A: The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000, 18:593-620
7. Segerer S, Nelson PJ, Schlondorff D: Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000, 11:152-176
8. Mori R, Kondo T, Ohshima T, Ishida Y, Mukaida N: Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration. FASEB J 2002, 16:963-974
9. Lin ZQ, Kondo T, Ishida Y, Takayasu T, Mukaida N: Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice. J Leukoc Biol 2003, 73:713-721
10. Amado M, Almeida R, Schwientek T, Clausen H: Identification and characterization of large galactosyltransferase gene families: galactosyltransferases for all functions. Biochim Biophys Acta 1999, 1473: 35-53
11. Hennet T: The galactosyltransferase family. Cell Mol Life Sci 2002, 59:1081-1095
12. McEver RP, Moore KL, Cummings RD: Leukocyte trafficking mediated by selectin-carbohydrate interactions. J Biol Chem 1995, 270: 11025-11028
13. Lowe JB: Selectin ligands, leukocyte trafficking, and fucosyltransferase genes. Kidney Int 1997, 51:1418-1426
14. Asano M, Furukawa K, Kido M, Matsumoto S, Umesaki Y, Kochibe N, Iwakura Y: Growth retardation and early death of β-1,4-galactosyltransferase knockout mice with augmented proliferation and abnormal differentiation of epithelial cells. EMBO J 1997, 16:1850-1857
15. Lu Q, Hasty P, Shur BD: Targeted mutation in β 1,4-galactosyltransferase leads to pituitary insufficiency and neonatal lethality. Dev Biol 1997, 181:257-267
16. Lu Q, Shur BD: Sperm from β1,4-galactosyltransferase-null mice are refractory to ZP3-induced acrosome reactions and penetrate the zona pellucida poorly. Development 1997, 124:4121-4131
17. Steffgen K, Dufraux K, Hathaway H: Enhanced branching morphogenesis in mammary glands of mice lacking cell surface β1,4-galactosyltransferase. Dev Biol 2002, 244:114-133
18. Asano M, Nakae S, Kotani N, Shirafuji N, Nambu A, Hashimoto N, Kawashima H, Hirose M, Miyasaka M, Takasaki S, Iwakura Y: Impaired selectin-ligand biosynthesis and reduced inflammatory responses in β -1,4-galactosyltransferase-I-deficient mice. Blood 2003, 102:1678-1685
19. Subramaniam M, Saffaripour S, Van De Water L, Frenette PS, Mayadas TN, Hynes RO, Wagner DD: Role of endothelial selectins in wound repair. Am J Pathol 1997, 150:1701-1709
20. Kotani N, Asano M, Iwakura Y, Takasaki S: Knockout of mouse β1,4-galactosyltransferase-1 gene results in a dramatic shift of outer chain moieties of N-glycans from type 2 to type 1 chains in hepatic membrane and plasma glycoproteins. Biochem J 2001, 357:827-834
21. -/- mice. Am J Pathol 2001, 159:457-463
22. Nakae S, Naruse-Nakajima C, Sudo K, Horai R, Asano M, Iwakura Y: IL-1 alpha, but not IL-1 beta, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity. Int Immunol 2001, 13:1471-1478
23. Woessner J: The determination of hydroxyproline in tissue and protein samples containing small proportions of the imino acid. Arch Biochem Biophys 1961, 93:440-447
24. Schrier DJ, Phan SH, McGarry BM: The effects of the nude (nu/nu) mutation on bleomycin-induced pulmonary fibrosis. A biochemical evaluation. Am Rev Respir Dis 1983, 127:614-617
25. Yokoi H, Natsuyama S, Iwai M, Noda Y, Mori T, Mori KJ, Fujita K, Nakayama H, Fujita J: Non-radioisotopic quantitative RT-PCR to detect changes in mRNA levels during early mouse embryo development. Biochem Biophys Res Commun 1993, 195:769-775
26. Nakayama H, Yokoi H, Fujita J: Quantification of mRNA by nonradioactive RT-PCR and CCD imaging system. Nucleic Acids Res 1992, 20:4939
27. Austyn JM, Gordon S: F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981, 11:805-815
28. Maly P, Thall A, Petryniak B, Rogers CE, Smith PL, Marks RM, Kelly RJ, Gersten KM, Cheng G, Saunders TL, Camper SA, Camphausen RT, Sullivan FX, Isogai Y, Hindsgaul O, von Andrian UH, Lowe JB: The α(1,3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell 1996, 86:643-653
29. Nelson PJ, Krensky AM: Chemokines, chemokine receptors, and allograft rejection. Immunity 2001, 14:377-386
30. Rappolee DA, Mark D, Banda MJ, Werb Z: Wound macrophages express TGF-α and other growth factors in vivo: analysis by mRNA phenotyping. Science 1988, 241:708-712
31. Frank S, Madlener M, Werner S: Transforming growth factors β1, β2, and β3 and their receptors are differentially regulated during normal and impaired wound healing. J Biol Chem 1996, 271:10188-10193
32. Ozawa K, Kondo T, Hori O, Kitao Y, Stern DM, Eisenmenger W, Ogawa S, Ohshima T: Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transport. J Clin Invest 2001, 108:41-50
33. Leibovich SJ, Ross R: The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol 1975, 78:71-100
34. Danon D, Kowatch MA, Roth GS: Promotion of wound repair in old mice by local injection of macrophages. Proc Natl Acad Sci USA 1989, 86:2018-2020
35. Nagaoka T, Kaburagi Y, Hamaguchi Y, Hasegawa M, Takehara K, Steeber DA, Tedder TF, Sato S: Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression. Am J Pathol 2000, 157:237-247
36. Dovi JV, He LK, DiPietro LA: Accelerated wound closure in neutrophil-depleted mice. J Leukoc Biol 2003, 73:448-455
37. Martin P, D'Souza D, Martin J, Grose R, Cooper L, Maki R, McKercher SR: Wound healing in the PU. 1 null mouse-tissue repair is not dependent on inflammatory cells. Curr Biol 2003, 13:1122-1128
38. Ashcroft GS, Lei K, Jin W, Longenecker G, Kulkarni AB, Greenwell-Wild T, Hale-Donze H, McGrady G, Song XY, Wahl SM: Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat Med 2000, 6:1147-1153
39. Ashcroft GS, Yang X, Glick AB, Weinstein M, Letterio JL, Mizel DE, Anzano M, Greenwell-Wild T, Wahl SM, Deng C, Roberts AB: Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1999, 1:260-266
40. Gagneux P, Varki A: Evolutionary considerations in relating oligosaccharide diversity to biological function. Glycobiology 1999, 9:747-755
41. Kishimoto TK, Hollander N, Roberts TM, Anderson DC, Springer TA: Heterogeneous mutations in the beta subunit common to the LFA-1, Mac-1, and p150,95 glycoproteins cause leukocyte adhesion deficiency. Cell 1987, 50:193-202
42. Luhn K, Wild MK, Eckhardt M, Gerardy-Schahn R, Vestweber D: The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter. Nat Genet 2001, 28:69-72
43. Lubke T, Marquardt T, Etzioni A, Hartmann E, von Figura K, Korner C: Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nat Genet 2001, 28:73-76
44. Anderson DC, Schmalsteig FC, Finegold MJ, Hughes BJ, Rothlein R, Miller LJ, Kohl S, Tosi MF, Jacobs RL, Waldrop TC, Groldman AS, Shearer WT, Springer TA: The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: their quantitative definition and relation to leukocyte dysfunction and clinical features. J Infect Dis 1985, 152:668-689
45. Roos D, Law SK: Hematologically important mutations: leukocyte adhesion deficiency. Blood Cells Mol Dis 2001, 27:1000-1004
46. Hansske B, Thiel C, Lubke T, Hasilik M, Honing S, Peters V, Heidemann PH, Hoffmann GF, Berger EG, von Figura K, Korner C: Deficiency of UDP-galactose:N-acetylglucosamine β-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId. J Clin Invest 2002, 109:725-733
47. Peters V, Penzien JM, Reiter G, Korner C, Hackler R, Assmann B, Fang J, Schaefer JR, Hoffmann GF, Heidemann PH: Congenital disorder of glycosylation IId (CDG-IId)-a new entity: clinical presentation with Dandy-Walker malformation and myopathy. Neuropediatrics 2002, 33:27-32